GPCR-Based Drug Discovery Conference 1 header


Suggested Package:

October 9

*Short Course:  GPCR Structured-Based Drug Discovery 

October 8-9:  GPCR-Targeted Therapeutics 


*Separate registration is required


About This Conference:

The renewed excitement in the field of GPCR drug discovery is due to technological progress which has enabled the collection of more structural data on GPCRs and is allowing study of receptors in different conformational states. This meeting will focus on structural aspects of GPCRs and new assays and technologies whose applications may enable the discovery of more selective and therefore therapeutically attractive modulators of GPCR signaling.


GPCR Molecular Simulations and Dynamics

The Secrets in Their Landscapes: Using ‘Google Exac’ to Elucidate Activation Mechanism of GPCRs for Selective Drug Design

Diwakar Shukla, Ph.D., Simbios Distinguished Fellow, Chemistry Department, Stanford University

Continuous Water Pathway Features GPCRs Ligand Specificities and Activation States

Shuguang Yuan, Ph.D., Computational Chemist, Drug Discovery, Actelion

Exploration of Drug Disease-Related Selectivity Using Molecular Simulations of the Bioamine Receptor Family

Irina Tikhonova, Ph.D., Lecturer in Molecular Modeling, School of Pharmacy, Queen's University Belfast


Structural Features of GPCRs and Implications for Drug Design

Function and Pharmacology of Class A GPCR: New structural and Computational Insights

Vsevolod (Seva) Katritch, Ph.D., Assistant Professor, Integrative Structural and Computational Biology, The Scripps Research Institute

Glucagon Receptor Structure

Fai Siu, Ph.D., Investigator II, Center for Proteomic Chemistry, Novartis Institute for BioMedical Research

Structure of a Class C GPCR 7TM Domain and Its Allosteric Modulation

Huixian Wu, Ph.D., Raymond C. Stevens Lab, Department of Integrative Structural and Computational Biology, The Scripps Research Institute

A Water-Soluble GPCR

Jeffrey G. Saven, Ph.D., Professor, Department of Chemistry, University of Pennsylvania


New Approaches for Studying GPCRs

Nanobody-Enabled Fragment Screening on Active-State Constrained GPCRs

Jan Steyaert, Ph.D., Director, Structural Biology Brussels Research Center, Vrije University Brussels

DOT CAG ICON 

green arrow CONFERENCE-AT-A-GLANCE 

PREMIER SPONSORS 

Cellecta 

green arrow VIEW ALL SPONSORS 

green arrow VIEW MEDIA PARTNERS 


SPONSORSHIPS & EXHIBITS 

The exhibit hall was sold out in 2013, so please contact us early to reserve your place. To customize your sponsorship or exhibit package for 2014, contact:

Jon Stroup
Business Development Manager
781-972-5483
jstroup@healthtech.com